T1	Outcomes 396 424	overall survival probability
T2	Outcomes 579 589	recurrence
T3	Outcomes 669 690	multivariate analysis
T4	Outcomes 814 831	nodal involvement
T5	Outcomes 872 888	age distribution
T6	Outcomes 917 941	sizofiran administration
T7	Outcomes 974 993	primary tumour size
